To establish the anti-melanoma selective effects of the novel HDAC/σ1R hybrid, complete antiproliferative dose–response curves were generated by employing two in vitro human models, the UM 92-1 cells and normal lung fibroblasts MRC-5 (Figure 2b). This evidence concerns the gene HDAC9 and melanoma.